Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 138 articles:
HTML format
Text format



Single Articles


    October 2019
  1. LIU Z, Behloul N, Baha S, Wei W, et al
    Design and immunogenicity analysis of the combined vaccine against zoonotic hepatitis E and foot-and-mouth disease.
    Vaccine. 2019 Oct 8. pii: S0264-410X(19)31245.
    PubMed     Text format     Abstract available


    September 2019
  2. OKENWA UJ, Dairo MD, Uba B, Ajumobi O, et al
    Maternal reasons for non-receipt of valid Hepatitis B birth dose among mother-infant pairs attending routine immunization clinics, South-east, Nigeria.
    Vaccine. 2019 Sep 24. pii: S0264-410X(19)31280.
    PubMed     Text format     Abstract available


  3. GROOM HC, Smith N, Irving SA, Koppolu P, et al
    Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study.
    Vaccine. 2019 Sep 20. pii: S0264-410X(19)31252.
    PubMed     Text format     Abstract available


  4. LOPES JLS, Oliveira DCA, Utescher CLA, Quintilio W, et al
    Antigenic and physicochemical characterization of Hepatitis B surface protein under extreme temperature and pH conditions.
    Vaccine. 2019 Sep 10. pii: S0264-410X(19)31193.
    PubMed     Text format     Abstract available


  5. WANG LY, Chen CF, Wu TW, Lai SK, et al
    Response to hepatitis B vaccination is co-determined by HLA-DPA1 and -DPB1.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31186.
    PubMed     Text format     Abstract available


    August 2019
  6. NGUYEN TT, Choi JA, Kim JS, Park H, et al
    Skin immunization with third-generation hepatitis B surface antigen using microneedles.
    Vaccine. 2019 Aug 26. pii: S0264-410X(19)31100.
    PubMed     Text format     Abstract available


  7. PARK BJ, Ahn HS, Han SH, Go HJ, et al
    Evaluation of the protective effects of a nanogel-based vaccine against rabbit hepatitis E virus.
    Vaccine. 2019 Aug 24. pii: S0264-410X(19)31093.
    PubMed     Text format     Abstract available


  8. XIA R, Sun S, Shen M, Zhang L, et al
    Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China.
    Vaccine. 2019 Aug 20. pii: S0264-410X(19)31040.
    PubMed     Text format     Abstract available


  9. HYER RN, Janssen RS
    Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60-70years.
    Vaccine. 2019 Aug 17. pii: S0264-410X(19)31044.
    PubMed     Text format     Abstract available


  10. PERRETT SE, Cottrell S, Shankar AG
    Hepatitis B vaccine coverage in short and long stay prisons in Wales, UK 2013-2017 and the impact of the global vaccine shortage.
    Vaccine. 2019;37:4872-4876.
    PubMed     Text format     Abstract available


    July 2019
  11. HADJ MB, Bouguerra H, Saffar F, Chelly S, et al
    Corrigendum to 'Observational study of vaccine effectiveness 20years after the introduction of universal hepatitis B vaccination in Tunisia' [Vaccine 36 (2018) 5858-5864].
    Vaccine. 2019 Jul 25. pii: S0264-410X(19)30321.
    PubMed     Text format    


  12. CHEN XX, Wagner AL, Zheng XB, Xie JY, et al
    Hepatitis E vaccine in China: Public health professional perspectives on vaccine promotion and strategies for control.
    Vaccine. 2019 Jul 25. pii: S0264-410X(19)30988.
    PubMed     Text format     Abstract available


  13. GIDUDU JF, Shaum A, Habersaat K, Wilhelm E, et al
    An approach for preparing and responding to adverse events following immunization reported after hepatitis B vaccine birth dose administration.
    Vaccine. 2019 Jul 20. pii: S0264-410X(19)30932.
    PubMed     Text format     Abstract available


  14. BRIDGES CB, Watson TL, Nelson NP, Chavez-Torres M, et al
    Challenges with hepatitis B vaccination of high risk adults - A pilot program.
    Vaccine. 2019 Jul 11. pii: S0264-410X(19)30746.
    PubMed     Text format     Abstract available


  15. ORK V, Woodring J, Shafiqul Hossain M, Wasley A, et al
    Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
    Vaccine. 2019 Jul 5. pii: S0264-410X(19)30850.
    PubMed     Text format     Abstract available


    June 2019
  16. YU XY, Chen ZP, Wang SY, Pan HR, et al
    Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65years.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30444.
    PubMed     Text format     Abstract available


  17. SONG S, Li P, Zhang R, Chen J, et al
    Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses.
    Vaccine. 2019 Jun 18. pii: S0264-410X(19)30787.
    PubMed     Text format     Abstract available


  18. NARAYANAN N, Elsaid MI, NeMoyer RE, Trivedi N, et al
    Disparities in hepatitis A virus (HAV) vaccination coverage among adult travelers to intermediate or high-risk countries: The role of birthplace and race/ethnicity.
    Vaccine. 2019 Jun 10. pii: S0264-410X(19)30708.
    PubMed     Text format     Abstract available


    April 2019
  19. SHEN EX, Lambert SB, Malo JA, Bennett S, et al
    Perinatal immunoprophylaxis in babies born to hepatitis B virus-positive mothers in Queensland Australia: A data linkage study.
    Vaccine. 2019 Apr 22. pii: S0264-410X(19)30526.
    PubMed     Text format     Abstract available


  20. ALBERTS CJ, Boyd A, Bruisten SM, Heijman T, et al
    Hepatitis A incidence, seroprevalence, and vaccination decision among MSM in Amsterdam, the Netherlands.
    Vaccine. 2019 Apr 13. pii: S0264-410X(19)30382.
    PubMed     Text format     Abstract available


  21. HARRIS AM, Millman AJ, Lora M, Osinubi A, et al
    Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients.
    Vaccine. 2019;37:2188-2193.
    PubMed     Text format     Abstract available


  22. NEUKAM K, Gutierrez-Valencia A, Llaves-Flores S, Espinosa N, et al
    Response to a reinforced hepatitis B vaccination scheme in HIV-infected patients under real-life conditions.
    Vaccine. 2019 Apr 10. pii: S0264-410X(19)30351.
    PubMed     Text format     Abstract available


  23. ECHEVARRIA D, Gutfraind A, Boodram B, Layden J, et al
    Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
    Vaccine. 2019 Apr 5. pii: S0264-410X(19)30319.
    PubMed     Text format     Abstract available


    March 2019
  24. ZHENG J, Ou Z, Xu Y, Xia Z, et al
    Hepatitis B virus-specific effector CD8(+) T cells are an important determinant of disease prognosis: A meta-analysis.
    Vaccine. 2019 Mar 29. pii: S0264-410X(19)30392.
    PubMed     Text format     Abstract available


  25. OSTER NV, Williams EC, Unger JM, Newcomb PA, et al
    Sociodemographic, clinical and birth hospitalization characteristics and infant Hepatitis B vaccination in Washington State.
    Vaccine. 2019 Mar 28. pii: S0264-410X(19)30384.
    PubMed     Text format     Abstract available


  26. FRITZSCHE C, Bergmann L, Loebermann M, Glass A, et al
    Immune response to hepatitis A vaccine in patients with HIV.
    Vaccine. 2019 Mar 16. pii: S0264-410X(19)30271.
    PubMed     Text format     Abstract available


  27. MOUCHET J, Begaud B
    Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period.
    Vaccine. 2019 Mar 6. pii: S0264-410X(19)30253.
    PubMed     Text format     Abstract available


  28. BURNY W, Marchant A, Herve C, Callegaro A, et al
    Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans.
    Vaccine. 2019 Mar 5. pii: S0264-410X(19)30209.
    PubMed     Text format     Abstract available


    February 2019
  29. KINGSTON NJ, Kurtovic L, Walsh R, Joe C, et al
    Hepatitis B virus-like particles expressing Plasmodium falciparum epitopes induce complement-fixing antibodies against the circumsporozoite protein.
    Vaccine. 2019 Feb 14. pii: S0264-410X(19)30132.
    PubMed     Text format     Abstract available


  30. RAMSAY LC, Anyiwe K, Li M, Macdonald L, et al
    Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30155.
    PubMed     Text format     Abstract available


  31. SHARP A, Coles S, Pegorie M, Harwood C, et al
    Vaccination strategies for control of community outbreaks of hepatitis A: A comparison of two outbreaks in England.
    Vaccine. 2019 Feb 12. pii: S0264-410X(19)30089.
    PubMed     Text format     Abstract available


  32. STASI C, Monnini M, Cellesi V, Salvadori M, et al
    Screening for hepatitis B virus and accelerated vaccination schedule in prison: A pilot multicenter study.
    Vaccine. 2019 Feb 4. pii: S0264-410X(19)30125.
    PubMed     Text format     Abstract available


    January 2019
  33. BORRAS E, Urbiztondo L, Carmona G, Jane M, et al
    Effectiveness and impact of the hepatitis B vaccination program in preadolescents in Catalonia 21 years after its introduction.
    Vaccine. 2019 Jan 29. pii: S0264-410X(19)30078.
    PubMed     Text format     Abstract available


  34. XU L, Li Z, Su Z, Yang Y, et al
    Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein.
    Vaccine. 2019 Jan 14. pii: S0264-410X(19)30054.
    PubMed     Text format     Abstract available


  35. SOUTO FJD, de Brito WI, Fontes CJF
    Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil.
    Vaccine. 2019 Jan 10. pii: S0264-410X(19)30010.
    PubMed     Text format     Abstract available


    December 2018
  36. VAN MULDER TJS, Withanage K, Beyers KCL, Vankerckhoven VVJ, et al
    Immunogenicity and safety of intradermal delivery of hepatitis B booster vaccine using the novel drug delivery device VAX-ID.
    Vaccine. 2018 Dec 23. pii: S0264-410X(18)31676.
    PubMed     Text format     Abstract available


  37. YANG YT, Huang AL, Zhao Y
    The prevalence of hepatitis B core antibody in vaccinated Chinese children: A hospital-based study.
    Vaccine. 2018 Dec 4. pii: S0264-410X(18)31630.
    PubMed     Text format     Abstract available


  38. LEIDNER AJ, Murthy N, Chesson HW, Biggerstaff M, et al
    Cost-effectiveness of adult vaccinations: A systematic review.
    Vaccine. 2018 Dec 4. pii: S0264-410X(18)31581.
    PubMed     Text format     Abstract available


    November 2018
  39. YU W, Lee LA, Liu Y, Scherpbier RW, et al
    Vaccine-preventable disease control in the People's Republic of China: 1949-2016.
    Vaccine. 2018 Nov 26. pii: S0264-410X(18)31357.
    PubMed     Text format     Abstract available


  40. NAGASHIMA S, Yamamoto C, Ko K, Chuon C, et al
    Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination.
    Vaccine. 2018 Nov 15. pii: S0264-410X(18)31541.
    PubMed     Text format     Abstract available


  41. WANG X, Li M, Lin Z, Pan H, et al
    Multifaceted characterization of recombinant protein-based vaccines: An immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine.
    Vaccine. 2018 Nov 2. pii: S0264-410X(18)31486.
    PubMed     Text format     Abstract available


    October 2018
  42. LOPEZ-GATELL H, Garcia-Garcia L, Echaniz-Aviles G, Cruz-Hervert P, et al
    Hepatitis A seroprevalence in adolescents and young adults in Mexico: A 2012 National Health and Nutrition Survey analysis.
    Vaccine. 2018 Oct 15. pii: S0264-410X(18)31403.
    PubMed     Text format     Abstract available


    September 2018
  43. BARTHOLOMEUS E, De Neuter N, Meysman P, Suls A, et al
    Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders.
    Vaccine. 2018 Sep 8. pii: S0264-410X(18)31236.
    PubMed     Text format     Abstract available


  44. GROOM HC, Irving SA, Koppolu P, Smith N, et al
    Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study.
    Vaccine. 2018 Sep 4. pii: S0264-410X(18)31214.
    PubMed     Text format     Abstract available


    August 2018
  45. OBANDO-PACHECO P, Rivero-Calle I, Gomez-Rial J, Rodriguez-Tenreiro Sanchez C, et al
    New perspectives for hexavalent vaccines.
    Vaccine. 2018;36:5485-5494.
    PubMed     Text format     Abstract available


  46. HADJ MB, Bouguerra H, Saffar F, Chelly S, et al
    Observational study of vaccine effectiveness 20years after the introduction of universal hepatitis B vaccination in Tunisia.
    Vaccine. 2018 Aug 22. pii: S0264-410X(18)31167.
    PubMed     Text format     Abstract available


  47. PHAM TT, Le HM, Nguyen DT, Maertens K, et al
    Assessment of the timely administration of the hepatitis B and BCG birth dose and the primary infant vaccination schedule in 2015-2016 in the Mekong Delta, Viet Nam.
    Vaccine. 2018 Aug 16. pii: S0264-410X(18)31109.
    PubMed     Text format     Abstract available


  48. ELWOOD JM, Ameratunga R
    Autoimmune diseases after hepatitis B immunization in adults: Literature review and meta-analysis, with reference to 'autoimmune/autoinflammatory syndrome induced by adjuvants' (ASIA).
    Vaccine. 2018 Aug 9. pii: S0264-410X(18)31094.
    PubMed     Text format     Abstract available


  49. DOBRICA MO, Lazar C, Paruch L, van Eerde A, et al
    Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice.
    Vaccine. 2018 Aug 3. pii: S0264-410X(18)31081.
    PubMed     Text format     Abstract available


    July 2018
  50. RAVEN S, Urbanus A, de Gee A, Hoebe C, et al
    Predictors of hepatitis B vaccination completion among people who use drugs participating in a national program of targeted vaccination.
    Vaccine. 2018 Jul 27. pii: S0264-410X(18)31014.
    PubMed     Text format     Abstract available


  51. KASPER AK, Pallotta AM, Kovacs CS, Spinner ML, et al
    Infectious diseases consult improves vaccination adherence in kidney transplant candidates.
    Vaccine. 2018 Jul 23. pii: S0264-410X(18)30899.
    PubMed     Text format     Abstract available


  52. SAITOH A, Okabe N
    Progress and challenges for the Japanese immunization program: Beyond the "vaccine gap".
    Vaccine. 2018;36:4582-4588.
    PubMed     Text format     Abstract available


    June 2018
  53. AUTA A, Adewuyi EO, Kureh GT, Onoviran N, et al
    Hepatitis B vaccination coverage among health-care workers in Africa: A systematic review and meta-analysis.
    Vaccine. 2018 Jun 30. pii: S0264-410X(18)30871.
    PubMed     Text format     Abstract available


  54. HECHTER RC, Qian L, Luo Y, Ling Grant DS, et al
    Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus.
    Vaccine. 2018 Jun 26. pii: S0264-410X(18)30863.
    PubMed     Text format     Abstract available


  55. BOHM K, Krause G, Sievers C
    Response to comment on: Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology.
    Vaccine. 2018;36:3885.
    PubMed     Text format    


  56. HERZOG C, Mayorga O
    Serologic differential diagnosis of hepatitis A virus (HAV) infected and vaccinated individuals: How long persist antibodies to non-structural HAV proteins?
    Vaccine. 2018;36:3883-3884.
    PubMed     Text format    


  57. GILLAM F, Zhang C
    Epitope selection and their placement for increased virus neutralization in a novel vaccination strategy for porcine epidemic diarrhea virus utilizing the Hepatitis B virus core antigen.
    Vaccine. 2018 Jun 15. pii: S0264-410X(18)30831.
    PubMed     Text format     Abstract available


  58. TRANTHAM L, Kurosky SK, Zhang D, Johnson KD, et al
    Adherence with and completion of recommended hepatitis vaccination schedules among adults in the United States.
    Vaccine. 2018 Jun 13. pii: S0264-410X(18)30788.
    PubMed     Text format     Abstract available


  59. FOUGERE Y, El Houss S, Suris JC, Rouvenaz-Defago S, et al
    High coverage of hepatitis B vaccination and low prevalence of chronic hepatitis B in migrant children dictate a new catch-up vaccination strategy.
    Vaccine. 2018 Jun 12. pii: S0264-410X(18)30825.
    PubMed     Text format     Abstract available


  60. RUSSO R, Bozzola E, Villani A
    Immunization of preterms with hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: The position of the Italian Pediatric Society.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30794.
    PubMed     Text format    


    May 2018
  61. LIU X, Yang C, Zhong Q, Song Q, et al
    Improved timely birth dose coverage of hepatitis B vaccine narrows the socio-economic inequality in western China in 2011-2016.
    Vaccine. 2018 May 26. pii: S0264-410X(18)30751.
    PubMed     Text format     Abstract available


  62. CHUAI X, Xie B, Chen H, Tan X, et al
    The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30681.
    PubMed     Text format     Abstract available


  63. HIRSH BAR GAI D, Graybill Z, Voevodsky P, Shittu E, et al
    Evaluating scenarios of locations and capacities for vaccine storage in Nigeria.
    Vaccine. 2018 May 14. pii: S0264-410X(18)30579.
    PubMed     Text format     Abstract available


  64. CHEAH BC, Davies J, Singh GR, Wood N, et al
    Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.
    Vaccine. 2018 May 4. pii: S0264-410X(18)30122.
    PubMed     Text format     Abstract available


  65. BREDBERG A, Boe OW, Bredberg J, Whist JE, et al
    Detection of hepatitis B surface antigen in blood following vaccination.
    Vaccine. 2018 May 4. pii: S0264-410X(18)30600.
    PubMed     Text format    


    April 2018
  66. LU PJ, O'Halloran AC, Williams WW, Nelson NP, et al
    Hepatitis B vaccination coverage among adults aged >/=18years traveling to a country of high or intermediate endemicity, United States, 2015.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30376.
    PubMed     Text format     Abstract available


  67. REEKIE J, Kaldor JM, Mak DB, Ward J, et al
    Long-term impact of childhood hepatitis B vaccination programs on prevalence among Aboriginal and non-Aboriginal women giving birth in Western Australia.
    Vaccine. 2018 Apr 26. pii: S0264-410X(18)30554.
    PubMed     Text format     Abstract available


  68. LINK-GELLES R, Hofmeister MG, Nelson NP
    Use of hepatitis A vaccine for post-exposure prophylaxis in individuals over 40years of age: A systematic review of published studies and recommendations for vaccine use.
    Vaccine. 2018 Apr 16. pii: S0264-410X(18)30484.
    PubMed     Text format     Abstract available


  69. TAVOSCHI L, Severi E, Carrillo Santisteve P, Lopalco P, et al
    Hepatitis A in the EU/EEA: The case for scaling up prevention.
    Vaccine. 2018 Apr 5. pii: S0264-410X(18)30299.
    PubMed     Text format    


  70. HYER R, McGuire DK, Xing B, Jackson S, et al
    Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults.
    Vaccine. 2018 Apr 5. pii: S0264-410X(18)30436.
    PubMed     Text format     Abstract available


    March 2018
  71. GARCIA D, Porras A, Rico Mendoza A, Alvis N, et al
    Hepatitis B infection control in Colombian Amazon after 15years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence.
    Vaccine. 2018 Mar 30. pii: S0264-410X(17)31546.
    PubMed     Text format     Abstract available


  72. LU PJ, O'Halloran AC, Williams WW, Nelson NP, et al
    Hepatitis B vaccination coverage among adults aged>/=18years traveling to a country of high or intermediate endemicity, United States, 2015.
    Vaccine. 2018 Mar 28. pii: S0264-410X(18)30375.
    PubMed     Text format     Abstract available


  73. LI X, Xu Y, Dong Y, Yang X, et al
    Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses.
    Vaccine. 2018 Mar 24. pii: S0264-410X(18)30389.
    PubMed     Text format     Abstract available


  74. WEI S, Lei Y, Yang J, Wang X, et al
    Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
    Vaccine. 2018 Mar 22. pii: S0264-410X(18)30381.
    PubMed     Text format     Abstract available


  75. KLINGER G, Chodick G, Levy I
    Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis.
    Vaccine. 2018 Mar 21. pii: S0264-410X(18)30373.
    PubMed     Text format     Abstract available


  76. LIU Y, Ma C, Jia H, Xu E, et al
    Knowledge, attitudes, and practices regarding hepatitis B vaccination among hospital-based doctors and nurses in China: Results of a multi-site survey.
    Vaccine. 2018 Mar 19. pii: S0264-410X(18)30354.
    PubMed     Text format     Abstract available


  77. ZHANG L, Yan B, Lv J, Liu J, et al
    Antibody response to hepatitis B vaccine is independently associated with hepatitis B breakthrough infection among adults: Results from a three-year follow-up study in China.
    Vaccine. 2018 Mar 13. pii: S0264-410X(18)30213.
    PubMed     Text format     Abstract available


  78. ZHENG M, Jiang J, Zhang X, Wang N, et al
    Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro.
    Vaccine. 2018 Mar 12. pii: S0264-410X(18)30341.
    PubMed     Text format     Abstract available


  79. SALAMA II, Sami SM, Said ZN, Salama SI, et al
    Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy.
    Vaccine. 2018 Mar 9. pii: S0264-410X(18)30313.
    PubMed     Text format     Abstract available


    February 2018
  80. YUE X, Black CL, O'Halloran A, Lu PJ, et al
    Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease.
    Vaccine. 2018;36:1183-1189.
    PubMed     Text format     Abstract available


  81. WANG D, Zhang Y, Ma C, Ma D, et al
    Live recombinant Lactococcuslactis expressing avian hepatitis virus ORF2 protein: Immunoprotection against homologous virus challenge in chickens.
    Vaccine. 2018;36:1108-1115.
    PubMed     Text format     Abstract available


  82. MOUCHET J, Salvo F, Raschi E, Poluzzi E, et al
    Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis.
    Vaccine. 2018 Feb 14. pii: S0264-410X(18)30210.
    PubMed     Text format     Abstract available


  83. FREIDL GS, Tostmann A, Curvers M, Ruijs WLM, et al
    Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016.
    Vaccine. 2018 Feb 14. pii: S0264-410X(18)30152.
    PubMed     Text format     Abstract available


  84. KOURKOUNTI S, Retsas T, Paparizos V, Tsimpidakis A, et al
    Evaluation of a convenient vaccination schedule against hepatitis B in HIV-patients with undetectable HIV viral load.
    Vaccine. 2018 Feb 12. pii: S0264-410X(18)30192.
    PubMed     Text format     Abstract available


  85. NELSON NP, Yankey D, Singleton JA, Elam-Evans LD, et al
    Hepatitis A vaccination coverage among adolescents (13-17years) in the United States, 2008-2016.
    Vaccine. 2018 Feb 12. pii: S0264-410X(18)30163.
    PubMed     Text format     Abstract available


  86. SUN X, Wang F, Zheng H, Miao N, et al
    The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004-2016.
    Vaccine. 2018 Feb 1. pii: S0264-410X(18)30092.
    PubMed     Text format     Abstract available


  87. YI X, Yuan Y, Li N, Yi L, et al
    A mouse model with age-dependent immune response and immune-tolerance for HBV infection.
    Vaccine. 2018;36:794-801.
    PubMed     Text format     Abstract available


    January 2018
  88. OMENACA F, Vazquez L, Garcia-Corbeira P, Mesaros N, et al
    Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity.
    Vaccine. 2018 Jan 11. pii: S0264-410X(18)30029.
    PubMed     Text format     Abstract available


  89. RAMIREZ A, Morris S, Maucourant S, D'Ascanio I, et al
    A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
    Vaccine. 2018 Jan 3. pii: S0264-410X(17)31814.
    PubMed     Text format     Abstract available


    December 2017
  90. GUPTA A, Popowich S, Ojkic D, Kurukulasuriya S, et al
    Inactivated and live bivalent fowl adenovirus (FAdV8b+FAdV11) breeder vaccines provide broad-spectrum protection in chicks against inclusion body hepatitis (IBH).
    Vaccine. 2017 Dec 29. pii: S0264-410X(17)31808.
    PubMed     Text format     Abstract available


  91. JACKSON S, Lentino J, Kopp J, Murray L, et al
    Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults.
    Vaccine. 2017 Dec 27. pii: S0264-410X(17)31791.
    PubMed     Text format     Abstract available


  92. SHIVE CL, Judge CJ, Clagett B, Kalayjian RC, et al
    Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection.
    Vaccine. 2017 Dec 15. pii: S0264-410X(17)31761.
    PubMed     Text format     Abstract available


  93. HABER P, Moro PL, Ng C, Lewis PW, et al
    Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31722.
    PubMed     Text format     Abstract available


  94. VON DELFT A, Donnison TA, Lourenco J, Hutchings C, et al
    The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes.
    Vaccine. 2017 Dec 1. pii: S0264-410X(17)31487.
    PubMed     Text format     Abstract available


    November 2017
  95. WEI KP, Zhu FC, Liu JX, Yan L, et al
    The efficacy of two different dosages of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing mother-to-child transmission of hepatitis B virus: A prospective cohort study.
    Vaccine. 2017 Nov 28. pii: S0264-410X(17)31601.
    PubMed     Text format     Abstract available


  96. CHEN Y, Zhou CL, Zhang XJ, Hao ZY, et al
    Immune memory at 17-years of follow-up of a single dose of live attenuated hepatitis A vaccine.
    Vaccine. 2017 Nov 25. pii: S0264-410X(17)31600.
    PubMed     Text format     Abstract available


  97. MORO PL, Zheteyeva Y, Barash F, Lewis P, et al
    Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016.
    Vaccine. 2017 Nov 23. pii: S0264-410X(17)31603.
    PubMed     Text format     Abstract available


  98. CHILDS L, Roesel S, Tohme RA
    Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.
    Vaccine. 2017 Nov 21. pii: S0264-410X(17)31591.
    PubMed     Text format     Abstract available


  99. PETIT D, Tevi-Benissan C, Woodring J, Hennessey K, et al
    Countries' interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31421.
    PubMed     Text format     Abstract available


  100. HUO C, Yang J, Lei L, Qiao L, et al
    Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
    Vaccine. 2017 Nov 9. pii: S0264-410X(17)31530.
    PubMed     Text format     Abstract available


    October 2017
  101. LANDI A, Law J, Hockman D, Logan M, et al
    Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes.
    Vaccine. 2017 Oct 28. pii: S0264-410X(17)31480.
    PubMed     Text format     Abstract available


  102. LU Y, Zhu FC, Liu JX, Zhai XJ, et al
    The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31428.
    PubMed     Text format     Abstract available


  103. WANG J, Qiu J, Zhu Y, Zhou H, et al
    Molecular evolution of hepatitis B vaccine escape variants in China, during 2000-2016.
    Vaccine. 2017;35:5808-5813.
    PubMed     Text format     Abstract available


  104. FUKUSHIMA S, Kiyohara T, Ishii K, Nakano T, et al
    Immunogenicity of aluminum-adsorbed hepatitis A vaccine (Havrix(R)) administered as a third dose after primary doses of Japanese aluminum-free hepatitis A vaccine (Aimmugen(R)) for Japanese travelers to endemic countries.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31357.
    PubMed     Text format     Abstract available


  105. PILEGGI C, Papadopoli R, Bianco A, Pavia M, et al
    Hepatitis B vaccine and the need for a booster dose after primary vaccination.
    Vaccine. 2017 Oct 5. pii: S0264-410X(17)31329.
    PubMed     Text format     Abstract available


    September 2017
  106. BOHM K, Filomena A, Schneiderhan-Marra N, Krause G, et al
    Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology.
    Vaccine. 2017 Sep 14. pii: S0264-410X(17)31189.
    PubMed     Text format     Abstract available


  107. OKADA Y, Uno N, Sato S, Mori S, et al
    Strong influence of human leukocyte antigen-DP variants on response to hepatitis B vaccine in a Japanese population.
    Vaccine. 2017 Sep 4. pii: S0264-410X(17)31133.
    PubMed     Text format     Abstract available


    August 2017
  108. JAYASUNDARA D, Hui BB, Regan DG, Heywood AE, et al
    Quantifying the population effects of vaccination and migration on hepatitis A seroepidemiology in Australia.
    Vaccine. 2017 Aug 17. pii: S0264-410X(17)31089.
    PubMed     Text format     Abstract available


  109. CAO YF, Tao H, Hu YM, Shi CB, et al
    A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine.
    Vaccine. 2017 Aug 10. pii: S0264-410X(17)30731.
    PubMed     Text format     Abstract available


  110. SCHLAUD M, Schmitz R, Poethko-Muller C, Kuhnert R, et al
    Vaccinations in the first year of life and risk of atopic disease - Results from the KiGGS study.
    Vaccine. 2017 Aug 8. pii: S0264-410X(17)31062.
    PubMed     Text format     Abstract available


  111. CADAVID-BETANCUR DA, Ospina MC, Hincapie-Palacio D, Bernal-Restrepo LM, et al
    Seroprevalence of hepatitis B and factors potentially associated in a population-based study in Medellin, Colombia.
    Vaccine. 2017 Aug 3. pii: S0264-410X(17)31010.
    PubMed     Text format     Abstract available


    July 2017
  112. HE H, Zhou Y, Xie S
    Assessment of the duplicate notifiable reporting of hepatitis B infection in Zhejiang province, China, 2005-2015.
    Vaccine. 2017 Jul 24. pii: S0264-410X(17)30947.
    PubMed     Text format     Abstract available


  113. WORLD HEALTH ORGANIZATION
    Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations.
    Vaccine. 2017 Jul 22. pii: S0264-410X(17)30954.
    PubMed     Text format     Abstract available


  114. PATEL DP, Treat JR, Castelo-Socio L
    Decreased Hepatitis B vaccine response in pediatric patients with atopic dermatitis, psoriasis, and morphea.
    Vaccine. 2017 Jul 20. pii: S0264-410X(17)30933.
    PubMed     Text format     Abstract available


  115. HUYNH C, Minuk GY, Uhanova J, Baikie M, et al
    Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Vaccine. 2017 Jul 20. pii: S0264-410X(17)30948.
    PubMed     Text format     Abstract available


  116. LI X, Heffelfinger J, Wiesen E, Diorditsa S, et al
    Improving hepatitis B birth dose coverage through village health volunteer training and pregnant women education.
    Vaccine. 2017 Jul 5. pii: S0264-410X(17)30853.
    PubMed     Text format     Abstract available


  117. ZHOU Y, He H, Deng X, Yan R, et al
    Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
    Vaccine. 2017 Jul 4. pii: S0264-410X(17)30875.
    PubMed     Text format     Abstract available


    June 2017
  118. LARA AN, Sartori AM, Fonseca MO, Lopes MH, et al
    Long-term protection after hepatitis B vaccination in people living with HIV.
    Vaccine. 2017 Jun 29. pii: S0264-410X(17)30827.
    PubMed     Text format     Abstract available


  119. ALLISON RD, Patel MK, Tohme RA
    Hepatitis B vaccine birth dose coverage correlates worldwide with rates of institutional deliveries and skilled attendance at birth.
    Vaccine. 2017 Jun 28. pii: S0264-410X(17)30848.
    PubMed     Text format     Abstract available


  120. WANG F, Zhang G, Zheng H, Miao N, et al
    Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Vaccine. 2017 Jun 23. pii: S0264-410X(17)30796.
    PubMed     Text format     Abstract available


  121. ZANETTI A, Desole MG, Romano L, d'Alessandro A, et al
    Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy.
    Vaccine. 2017 Jun 14. pii: S0264-410X(17)30683.
    PubMed     Text format     Abstract available


  122. RAMIREZ-SOTO MC, Ortega-Caceres G, Cabezas C
    Trends in mortality burden of hepatocellular carcinoma, cirrhosis, and fulminant hepatitis before and after roll-out of the first pilot vaccination program against hepatitis B in Peru: An analysis of death certificate data.
    Vaccine. 2017 Jun 8. pii: S0264-410X(17)30756.
    PubMed     Text format     Abstract available


  123. CHEN MS JR, Dang JH
    What might we learn from the more successful uptake of Hepatitis B (HBV) vaccinations to increase Human Papillomavirus (HPV) vaccinations in adolescents?
    Vaccine. 2017 Jun 8. pii: S0264-410X(17)30746.
    PubMed     Text format    


  124. MARTINON-TORRES F, Boisnard F, Thomas S, Sadorge C, et al
    Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
    Vaccine. 2017 Jun 2. pii: S0264-410X(17)30679.
    PubMed     Text format     Abstract available


    May 2017
  125. SYED SF, Sun Y, Du T, Chen Y, et al
    Evaluation of recombinant Chinese avian hepatitis E virus (CaHEV) ORF2 and ORF3 proteins for protection of chickens against CaHEV infection.
    Vaccine. 2017 May 18. pii: S0264-410X(17)30638.
    PubMed     Text format     Abstract available


  126. DENG Y, Chuai X, Chen P, Chen H, et al
    Recombinant vaccinia vector-based vaccine (Tiantan) boosting a novel HBV subunit vaccine induced more robust and lasting immunity in rhesus macaques.
    Vaccine. 2017 May 6. pii: S0264-410X(17)30551.
    PubMed     Text format     Abstract available


  127. MANGEN MJ, Stibbe H, Urbanus A, Siedenburg EC, et al
    Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30560.
    PubMed     Text format     Abstract available


  128. WONG CKH, Liao Q, Guo VYW, Xin Y, et al
    Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30542.
    PubMed     Text format     Abstract available


    April 2017
  129. WICHGERS SCHREUR PJ, van Keulen L, Kant J, Kortekaas J, et al
    Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30498.
    PubMed     Text format     Abstract available


  130. LU PJ, O'Halloran A, Kennedy ED, Williams WW, et al
    Awareness among adults of vaccine-preventable diseases and recommended vaccinations, United States, 2015.
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30503.
    PubMed     Text format     Abstract available


  131. SIL A, Ravi MD, Patnaik BN, Dhingra MS, et al
    Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants.
    Vaccine. 2017 Apr 24. pii: S0264-410X(17)30315.
    PubMed     Text format     Abstract available


  132. SEREMBA E, Van Geertruyden JP, Ssenyonga R, Opio CK, et al
    Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
    Vaccine. 2017 Apr 20. pii: S0264-410X(17)30484.
    PubMed     Text format     Abstract available


  133. BREAKWELL L, Anga J, Dadari I, Sadr-Azodi N, et al
    Evaluation of storing hepatitis B vaccine outside the cold chain in the Solomon Islands: Identifying opportunities and barriers to implementation.
    Vaccine. 2017 Apr 18. pii: S0264-410X(17)30473.
    PubMed     Text format     Abstract available


  134. JIANG HY, Wang SY, Deng M, Li YC, et al
    Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: A systematic review and meta-analysis.
    Vaccine. 2017 Apr 9. pii: S0264-410X(17)30432.
    PubMed     Text format     Abstract available


    March 2017
  135. LOBAINA Y, Michel ML
    Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials.
    Vaccine. 2017 Mar 25. pii: S0264-410X(17)30366.
    PubMed     Text format     Abstract available


  136. SHI J, Feng Y, Gao L, Feng D, et al
    Immunogenicity and safety of a high-dose hepatitis B vaccine among patients receiving methadone maintenance treatment: A randomized, double-blinded, parallel-controlled trial.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30340.
    PubMed     Text format     Abstract available


  137. XU B, Zhu D, Bi Y, Wang Y, et al
    Minimal association of alleles of human leukocyte antigen class II gene and long-term antibody response to hepatitis B vaccine vaccinated during infancy.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30327.
    PubMed     Text format     Abstract available


    December 2016
  138. RISSMANN M, Ulrich R, Schroder C, Hammerschmidt B, et al
    Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine.
    Vaccine. 2016 Dec 21. pii: S0264-410X(16)31197.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: